Skip Navigation
You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
U.S. Department of Health and Human Services
•
National Institutes of Health
Advanced Search
NIAID Home
Health & Research A to Z
Labs & Scientific Resources
Funding
About NIAID
News & Events
NIAID
>
Health & Research Topics
>
Biodefense and Related Programs
>
Chemical Countermeasures
>
Research Areas
>
Skin, Eyes, and Mucous Membranes
Skip Website Tools
Website Tools
Email this page
Print this page
Get email updates
Get plug-ins and viewers
Order publications
Skip Stay Connected
Stay Connected
Additional Information From NIAID
Resources for Researchers
NIH Strategic Plan and Research Agenda for Medical Countermeasures Against Chemical Threats
(PDF 3 MB)
Biodefense and Emerging Infectious Diseases
—The NIAID Biodefense website includes biodefense-related information for biomedical researchers, the public, and the media.
External Resources
National Institute of Neurological Disorders and Stroke
National Institute of Environmental Health Sciences
View a list of links
for more information about Medical Countermeasures Against Chemical Threats
Javascript Error
Your browser JavaScript is turned off causing certain features of the NIAID Institute of Allergy and Infectious Diseases web site to work incorrectly. Please visit your browser settings and turn JavaScript on.
Read more information on enabling JavaScript.
Medical Countermeasures Against Chemical Threats
Skip Content Marketing
Share this:
Skin, Eyes, and Mucous Membranes
Long-Term Goals
Develop novel therapeutic strategies, including reactive therapeutic compounds, to prevent blister formation and inflammatory effects in skin and eyes
Evaluate the effectiveness of new immunotherapeutic compounds and their applicability in the treatment of injuries caused by acids, alkalis, or sulfur mustard
Identify the mechanisms of action of specific chemical agents and their sites of injury to the skin, eyes, and mucous membranes, from the systemic to the molecular level
Investigate the healing mechanisms following chemical injury, and identify novel ways of accelerating the recovery process
Identify and utilize information about the mechanisms of action of vesicants on tissues, organs, and the hematopoetic system for the development of therapeutic interventions
Evaluate novel therapeutic strategies for acid- and alkali-induced injuries
Identify biological markers consistent with exposure to various types of chemical agents and levels of exposure to such agents
Evaluate “reactive” or “catalytic” skin protectants for use in civilian populations, such as first responders who must operate in a contaminated environment
Evaluate decontamination approaches for patients with open-wound injuries, and identify novel opportunities for medical intervention
Develop practical therapies that can be administered easily and safely to decontaminate the skin during mass casualty situations
back to top
Last Updated February 29, 2008